- The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: Multiple myeloma, lymphoma, and acute leukemia. Journal for ImmunoTherapy of Cancer. 2016 Academic Article GET IT
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
The New England journal of medicine.
Times cited: 970
Active idiotypic vaccination versus control immunotherapy for follicular lymphoma.
Journal of Clinical Oncology.
Times cited: 24